Use of MLN51 gene and protein
US8513028B2 · kind B2 · utility
7Cited by
0References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2007 |
| Grant date | Aug 20, 2013 |
| Priority date | — |
| Expiry date | Dec 7, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel uses of the MLN 51 gene or protein. The MLN 51 gene and protein is closely related to the development of rheumatoid arthritis and serve as biomarker and therapeutic target for rheumatoid arthritis, particularly chronic synovitis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.